|
|
Interim report |
|
|
SciBase announces outcome in directed share issue |
|
|
SciBase Launches Nevisense Pilot at Leading University in Southeast Florida |
|
|
A new important customer in the US, Palm Beach Dermatology Group, has placed an initial order for 6 Nevisense. |
|
|
SciBase announces outcome in directed share issue |
|
|
SciBase resolves on a directed share issue of approximately SEK 11 million |
|
|
Bulletin from the annual general meeting in SciBase Holding AB (publ) |
|
|
SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million |
|
|
SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30 |
|
|
SciBase Initiates Self-Pay Model in the US to Make Nevisense Test More Accessible to Patients |
